488
Participants
Start Date
February 27, 2020
Primary Completion Date
November 30, 2022
Study Completion Date
November 30, 2022
Lumateperone
Lumateperone 42mg oral capsule
Placebos
Placebo oral capsule
Clinical Site, Sofia
Clinical Site, Kyiv
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Vratsa
Clinical Site, Plovdiv
Clinical Site, Veliko Tarnovo
Clinical Site, Kardzhali
Clinical Site, Rousse
Clinical Site, Burgas
Clinical Site, Varna
Clinical Site, New York
Clinical Site, Belgrade
Clinical Site, Cedarhurst
Clinical Site, Smila
Clinical Site, Vinnytsia
Clinical Site, Kovin
Clinical Site, Charlotte
Clinical Site, Decatur
Clinical Site, Atlanta
Clinical Site, Orange City
Clinical Site, Miami
Clinical Site, Lauderhill
Clinical Site, Kragujevac
Clinical Site, Poltava
Clinical Site, O'Fallon
Clinical site, Odesa
Clinical Site, Odesa
Clinical Site, Lviv
Clinical Site, Sherman Oaks
Clinical Site, Oceanside
Clinical Site, Garden Grove
Clinical Site, Bellevue
Clinical Site, Moscow
Clinical Site, Saint Petersburg
Clinical Site, Saint Petersburg
Clinical Site, Saint Petersburg
Clinical Site, Saint Petersburg
Clinical Site, Saint Petersburg
Clinical Site, Yekaterinburg
Clinical Site, Tomsk
Lead Sponsor
Intra-Cellular Therapies, Inc.
INDUSTRY